New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions
30. April 2018 09:20 ET
|
Biodesix, Inc.
- First Data Showing Prognostic Value of Test Among Patients by Performance Status Presented at ACMQ Annual Meeting – - Optimizing Best Supportive Care and Avoiding Overtreatment Creates an Expected...
New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC
18. April 2018 09:00 ET
|
Biodesix, Inc.
BOULDER, Colo., April 18, 2018 (GLOBE NEWSWIRE) -- Biodesix®, Inc. is presenting new data today demonstrating the ability of the company’s droplet digital PCR (ddPCR™)-based platform to reliably...
Biodesix Announces Data To Be Presented at AACR Annual Meeting 2018
05. April 2018 10:00 ET
|
Biodesix, Inc.
BOULDER, Colo., April 05, 2018 (GLOBE NEWSWIRE) -- Biodesix®, Inc. will present new data confirming the ability of the company’s droplet digital PCR (ddPCR™)-based platform to reliably detect key...
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
20. März 2018 09:00 ET
|
Biodesix, Inc.
BOULDER, Colo., March 20, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate...
Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners
05. März 2018 13:26 ET
|
Biodesix, Inc.
BOULDER, Colo., March 05, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc., a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology, today...
Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch
31. Januar 2018 09:00 ET
|
Biodesix, Inc.
BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix® announced a new collaboration agreement with PD-L1 expert Professor Fred R. Hirsch, MD, PhD, laboratory director at the Hirsch Biomarker...
MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference
19. Januar 2018 16:56 ET
|
Biodesix, Inc.
ADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Science Showcase”...
Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors
20. Dezember 2017 10:00 ET
|
Biodesix, Inc.
BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test...
Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress
05. Dezember 2017 06:00 ET
|
Biodesix, Inc.
BOULDER, Colo., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Biodesix provided updates and data related to the company’s on-market and in-development liquid biopsy tests at the 2017 qPCR & Digital PCR...
Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test
16. November 2017 15:40 ET
|
Biodesix, Inc.
BOULDER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Biodesix® announced data demonstrating that a novel, automated method for extracting circulating RNA from plasma performed equivalently or better...